建泉国际控股(08365.HK)斥4,000万元收购雅博集团国际 溢价11.1%发行代价股份及CB支付
建泉国际控股(08365.HK)公布,斥4,000万元收购雅博集团国际全部已发行股份,其中1,000万元将以发行及配发5,000万股代价股份之方式支付,其余3,000万则以发行可换股票据之方式支付,若获悉数行使将发行及配发合共1.5亿股换股股份,相关股份分别占公司扩大後股本8.88%及21.03%。
代价股份发行价及可换股票据之兑换价均为0.2元,较公司上一个交易日收市价溢价11.1%。
收购业务於香港从事提供环境、社会及管治顾问服务、公司秘书服务、会计及税务服务、风险管理及内部监控顾问服务、招聘代理服务,及资讯科技服务。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.